Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Human Immunology|September 30, 2008
Alloantigen-induced regulatory CD8+CD103+ T cellsSven D Koch, Elena Uss, René A W van Lier, et al.
Vaccines|April 23, 2022
A Third Dose of the COVID-19 Vaccine, CVnCoV, Increased the Neutralizing Activity against the SARS-CoV-2 Wild-Type and Delta VariantOlaf-Oliver Wolz, Sarah-Katharina Kays, Helga Junker, et al.
Human Vaccines & Immunotherapeutics|August 8, 2013
A novel, disruptive vaccination technology: self-adjuvanted RNActive(®) vaccinesKarl-Josef Kallen, Regina Heidenreich, Margit Schnee, et al.
Vaccine|February 25, 2019
RNA-based adjuvant CV8102 enhances the immunogenicity of a licensed rabies vaccine in a first-in-human trialFatma Doener, Henoch S Hong, Ingo Meyer, et al.
Cancer Research|October 22, 2009
Simultaneous infiltration of polyfunctional effector and suppressor T cells into renal cell carcinomasSebastian Attig, Jörg Hennenlotter, Graham Pawelec, et al.
Oncoimmunology|January 27, 2017
Distinct transcriptional changes in non-small cell lung cancer patients associated with multi-antigenic RNActive® CV9201 immunotherapyHenoch S Hong, Sven D Koch, Birgit Scheel, et al.
Kidney International|August 13, 2010
Maintenance immunosuppressive therapy with everolimus preserves humoral immune responsesGeertrude H Struijk, Robert C Minnee, Sven D Koch, et al.
BMC Cancer|October 8, 2014
Phase Ib study evaluating a self-adjuvanted mRNA cancer vaccine (RNActive®) combined with local radiation as consolidation and maintenance treatment for patients with stage IV non-small cell lung cancerMartin Sebastian, Alexandros Papachristofilou, Christian Weiss, et al.
Vaccines|April 27, 2024
Innate Responses to the Former COVID-19 Vaccine Candidate CVnCoV and Their Relation to Reactogenicity and Adaptive ImmunogenicityOlaf-Oliver Wolz, Dominik Vahrenhorst, Gianluca Quintini, et al.
International Immunology|July 28, 2012
Analysis of stem-cell-like properties of human CD161++IL-18Rα+ memory CD8+ T cellsSimone H C Havenith, Si La Yong, Sian M Henson, et al.
Pageof 2